Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “White Blood Cell Count, Leukocytes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00469378
What this trial is testing

Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
GlaxoSmithKline 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT03801434
What this trial is testing

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

Who this might be right for
BCR-JAK2 Fusion Protein ExpressionBlasts 20 Percent or Less of Peripheral Blood White CellsBlasts More Than 5 Percent of Bone Marrow Nucleated Cells+9 more
Stanford University 8
Testing effectiveness (Phase 2)Ended earlyNCT00937053
What this trial is testing

Maintaining a Higher Level of Haemoglobin: Effect on the White Cells After Bone Marrow Transplantation in Children.

Who this might be right for
Neutropenia
St. Justine's Hospital 6
Not applicableAvailableNCT06956547
What this trial is testing

Expanded Access Use of Nogapendekin-alfa Inbakicept in the Reversal and Maintenance of Absolute Lymphocyte Count (ALC) for the Treatment of Lymphopenia Induced by Chemotherapy, Immunotherapy, and/or Radiation Therapy

Who this might be right for
Lymphopenia
ImmunityBio, Inc.
Not applicableStudy completedNCT01388725
What this trial is testing

Comparison the Value of Several Biomarkers of Sepsis

Who this might be right for
Systemic Inflammatory Response SyndromeSepsis
Chinese PLA General Hospital 130
Early research (Phase 1)Study completedNCT02766647
What this trial is testing

A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Who this might be right for
Neutropenia (Low White Blood Cell Count)
Pfizer 24
Early research (Phase 1)Study completedNCT04723602
What this trial is testing

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
Albert B. Sabin Vaccine Institute 32
Early research (Phase 1)Study completedNCT02766634
What this trial is testing

A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Who this might be right for
Neutropenia (Low White Blood Cell Count)
Pfizer 60
Testing effectiveness (Phase 2)Ended earlyNCT02906696
What this trial is testing

Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure

Who this might be right for
Blasts Under 15 Percent of Bone Marrow Nucleated CellsBlasts Under 15 Percent of Peripheral Blood White CellsBlasts Under 30 Percent of Bone Marrow Nucleated Cells+2 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)WithdrawnNCT03881735
What this trial is testing

Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation

Who this might be right for
Blasts Under 5 Percent of Peripheral Blood White CellsBone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment LevelIDH2 Gene Mutation+2 more
Roswell Park Cancer Institute
Not applicableNot Yet RecruitingNCT07471061
What this trial is testing

Acute Ischemic Stroke Involves Significant Inflammatory Response. This Prospective Cohort Study Evaluates the Predictive Value of Monocyte-, Neutrophil-, and Leukocyte-to-albumin Ratios for Stroke Severity and Functional Outcome Using NIHSS at Admission and Modified Rankin Scale During Follow-up.

Who this might be right for
Acute Ischemic Stroke (AIS)
Sohag University 60
Not applicableWithdrawnNCT04643860
What this trial is testing

Differential Leucocyte Count and Covid-19 Diagnosis

Who this might be right for
SARS-CoV-2 Infection Covid19
Neuromed IRCCS
Not applicableActive Not RecruitingNCT04174742
What this trial is testing

Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

Who this might be right for
BreastBreast Cancer
Wake Forest University Health Sciences 115
Not applicableUnknownNCT03495492
What this trial is testing

Chronic Lymphocytic Leukemia Responds to Dermal Chelation

Who this might be right for
Chronic Lymphocytic Leukemia
Optimum Health, Natural Healthcare Center 50
Testing effectiveness (Phase 2)WithdrawnNCT03851081
What this trial is testing

Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientBlasts 5 Percent or More of Bone Marrow Nucleated CellsBlasts 5 Percent or More of Peripheral Blood White Cells+5 more
Roswell Park Cancer Institute
Not applicableUnknownNCT06360952
What this trial is testing

A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC

Who this might be right for
LeukopeniaLeukocytosisNeutropenia
Tasso Inc. 40
Testing effectiveness (Phase 2)UnknownNCT06143735
What this trial is testing

Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 99
Not applicableStudy completedNCT05159024
What this trial is testing

Role of Procalcitonin, C-Reactive Protein, and WBC Count in Prediction of Colorectal Anastomotic Leak

Who this might be right for
Anastomotic Leak
Suez Canal University 205
Very early researchLooking for participantsNCT07066085
What this trial is testing

Serial Blood Count Study

Who this might be right for
Cyclic NeutropeniaCongenital NeutropeniaNeutropenia
University of Washington 20
Not applicableWithdrawnNCT03551847
What this trial is testing

The Effect of Oral Antibiotics on Synovial Fluid and Differential for the Diagnosis of Infection

Who this might be right for
Infection
Rush University Medical Center
Next Page